$BBY

SCHULZE RICHARD M sold $74.0M of BBY (indirect holdings)

SCHULZE RICHARD M sold 900,000 indirectly-held shares of BEST BUY CO INC (BBY) at an average of $82.21 ($80.88–$83.63, $73.99M total) across 7 trades over 2026-07-13 to 2026-07-14 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · SCHULZE RICHARD M
Published Jul 15, 2026, 8:39 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 15, 2026, 8:42 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$BBY
Neutral
medium confidence
Mentioned
$BBY
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BBYNeutralLow
01

Why it matters

The disclosure updates the record of insider activity, but it does not provide new information about Best Buy’s business performance, guidance, or strategy.

02

Market read

A large insider sale is newly disclosed, but the 10b5-1 framing suggests limited incremental fundamental signal.

03

What to watch

Traders may overreact to insider selling size; the key nuance is the 10b5-1 designation and the absence of any accompanying company news in the filing.

Relevance 7/10Novelty 5/10Timing: Filed after-hours on 2026-07-15, covering sales dated 2026-07-13 to 2026-07-14.

Background

The article is an SEC Form 4 insider transaction disclosure for Best Buy Co. Inc. (BBY).

Company-level read

Ticker impact

$BBYNeutralMedium confidence
Context

Best Buy insider Richard M. Schulze sold about 900,000 shares in open-market trades for roughly $74.0M under a 10b5-1 plan.

Expected impact

Likely limited, short-lived sentiment impact; follow-through depends on broader tape and any additional disclosures.

Evidence & confidence

The filing is a Form 4 insider transaction with explicit 10b5-1 pre-arrangement, which typically reduces interpretive weight versus discretionary selling.

Market effects

Minimal sector read-through; this is company-specific insider selling with no operational or guidance change disclosed.

None indicated.

None indicated.

Counterpoint

Because the sale is under a pre-arranged 10b5-1 plan, it may reflect routine liquidity rather than bearish expectations, limiting any sustained price effect.

Key entities

  • BBY

    Best Buy Co. Inc., the company whose insider transaction is disclosed.

  • SCHULZE RICHARD M

    Insider reporting open-market sale of shares via an indirect holding structure.

  • 10b5-1 plan

    Pre-arranged plan cited as Yes, which typically reduces interpretive weight of the sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$BBYMed

Best Buy's AI Push Drives Digital Growth & Retail Momentum

Best Buy (BBY) reported Q2 2027 revenue growth of 3.6% to $9.8B, with comparable sales up 4.1%. Computing led growth, and emerging categories like AI glasses saw sales double. The company raised its Marketplace forecast to $1.3B. BBY's stock rose 26.5% in 3 months, with a P/S ratio of 0.48. Earnings estimates were revised upward.

$BBYMed

Sportsman's Warehouse (NASDAQ:SPWH): Strongest Q2 Results from the Specialty Retail Group

Best Buy (BBY) reported Q2 revenue of $9.78B, up 3.6% YoY, beating estimates. Its stock rose 3.7% post-earnings. Dick's (DKS) reported $5.59B revenue, up 53.2% YoY, missing estimates. Its stock fell 24.7%. Sally Beauty (SBH) reported flat revenue of $935.5M, meeting expectations. Bath & Body Works (BBWI) reported $1.51B revenue, down 2.3% YoY, beating estimates. Its stock rose 4.8%.

$BBYHighAI 8/10

Best Buy stock hits 52-week high at 91.27 USD

Best Buy (BBY) stock hit a 52-week high of $91.27, up 18.5% over the past year. The company reported Q2 2027 earnings of $1.47 per share on revenue of $9.78B, beating estimates. Analysts have mixed views, with some raising price targets to $95 and others downgrading due to valuation concerns.